Incidence of Pneumocystis jiroveci Pneumonia among Groups at Risk in HIV-negative Patients, The American Journal of Medicine, vol.127, issue.12, pp.1242-1253, 2014. ,
DOI : 10.1016/j.amjmed.2014.07.010
URL : https://hal.archives-ouvertes.fr/hal-01063911
Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients, Pneumocystis jirovecii pneumonia in patients with or without AIDS, p.5590, 2014. ,
A survey of rheumatologists' practice for prescribing pneumocystis prophylaxis Guidelines on Post-Exposure Prophylaxis for HIV and the Use of Co-Trimoxazole Prophylaxis for HIV-Related Infections Among Adults, Adolescents and Children: Recommendations for a Public Health Approach: December 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2014. (WHO Guidelines Approved by the Guidelines Review Committee). available on Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: a strategy for prevention, 792?9. 5, p.42, 2004. ,
An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients, American Journal of Respiratory and Critical Care Medicine, vol.183, issue.1, pp.96-128, 2011. ,
DOI : 10.1164/rccm.2008-740ST
A Randomized Trial of Three Antipneumocystis Agents in Patients with Advanced Human Immunodeficiency Virus Infection, New England Journal of Medicine, vol.332, issue.11, pp.693-702, 1995. ,
DOI : 10.1056/NEJM199503163321101
Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: A retrospective study 2002???2004, Scandinavian Journal of Infectious Diseases, vol.80, issue.6-7, pp.589-95, 2007. ,
DOI : 10.1007/s150100070041
Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection Pneumocystis jirovecii pneumonia in systemic autoimmune rheumatic disease: A case-control study. Semin Arthritis Rheum Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by realtime PCR: a 4-year prospective study Pneumocystis jirovecci pneumonia in connective tissue diseases: Comparison with other immunocompromised patients, 712?20. 11. Tadros S,3370?6. 13. Teichtahl AJ, pp.86-90, 2000. ,
Risk of Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis treated with inhibitors of tumour necrosis factor ?: results from the British Society for Prognostic factors of Pneumocystis jirovecii pneumonia in patients without HIV infection Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS Anti-CD20 antibody therapy and susceptibility to Pneumocystis pneumonia al. Low incidence of pneumocystis pneumonia utilizing PCR-based diagnosis in patients with Bcell lymphoma receiving rituximab-containing combination chemotherapy, 1336?7. 1588?95. 16. Limper AH, pp.2043-52, 1989. ,
Primary immunodeficiencies underlying fungal infections, Current Opinion in Pediatrics, vol.25, issue.6, pp.736-783, 2013. ,
DOI : 10.1097/MOP.0000000000000031
The multiple facets of glucocorticoid action in rheumatoid arthritis, 645?55. Supplementary method Specimen processing and analysis, 2012. ,
DOI : 10.1210/en.2010-0456
TIB MOLBIOL) according to the manufacturer's instructions. The target gene was a multi-copy gene coding for Major Surface Glycoprotein ,
Ten-minute silverstain for P. carinii and fungi in tissue sections, Arch Pathol Lab Med, vol.106, pp.292-94, 1982. ,
Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients, International Journal of Infectious Diseases, vol.46, pp.11-18, 2016. ,
DOI : 10.1016/j.ijid.2016.03.018
Successful chemoprophylaxis for Pneumocystis carinii pneumonitis Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients, 1419?26. 3. Stern A, p.5590, 1977. ,
Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents: Updated Guidelines From the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.58, issue.9, pp.1308-1319, 2014. ,
DOI : 10.1093/cid/ciu094
The KDIGO clinical practice guidelines for the care of kidney transplant recipients. Transplantation. 27 mars, pp.644-649, 2010. ,
pneumonia in patients with haematological malignancies and stem cell transplant recipients, Journal of Antimicrobial Chemotherapy, vol.71, issue.9, pp.2397-404, 2016. ,
DOI : 10.1093/jac/dkw157
URL : https://hal.archives-ouvertes.fr/pasteur-01405216
Peripheral Blood CD4 + T-Lymphocyte Counts During Pneumocystis carinii Pneumonia in Immunocompromised Patients Without HIV Infection, Chest, vol.118, issue.3, pp.712-732, 2000. ,
DOI : 10.1378/chest.118.3.712
Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the Fungi, Nature, vol.334, issue.6182, pp.519-541, 1988. ,
DOI : 10.1038/334519a0
Sterol biosynthesis and sterol uptake in the fungal pathogen Pneumocystis carinii, FEMS Microbiology Letters, vol.311, issue.1, pp.1-9, 2010. ,
DOI : 10.1111/j.1574-6968.2010.02007.x
Pneumocystis carinii is not universally transmissible between mammalian species, Infect Immun. juill Genetics, metabolism and host specificity of Pneumocystis carinii. Med Mycol, vol.6136, issue.11 1, pp.183-93, 1993. ,
Pneumocystis carinii, as the agent pf interstitial plasma cell pneumonia in man, Bol Inst Pueric. avr, vol.21, pp.5-16, 1964. ,
Pneumocystis carinii Nomenclature: Response to Cushion and Stringer, Clinical Infectious Diseases, vol.42, issue.8, pp.1208-1217, 2006. ,
DOI : 10.1086/503041
Cold Spring Harb Perspect Med ,
Pneumocystis species, co-evolution and pathogenic power Quantitation of absolute Pneumocystis carinii nuclear DNA content. Trophic and cystic forms isolated from infected rat lungs are haploid organisms, 233?9. 17. Thomas CF, Limper AH. Current insights into the biology and pathogenesis of Pneumocystis pneumonia, pp.708-734, 1998. ,
[Parasitic pneumonia Interstitial plasma cell pneumonia of premature, caused by pneumocystis Carinii]. Zentralblatt Bakteriol Parasitenkd Infekt Hyg Zweite Naturwissenschaftliche Abt Allg Landwirtsch Tech Mikrobiol. 12 mai 1952 Pneumocystis pneumonia--Los, 1?2):120?7. 19. Centers for Disease Control and Prevention (CDC) ,
Pneumocystis colonization is highly prevalent in the autopsied lungs of the general population, Clin Infect Dis Off Publ Infect Dis Soc Am. 1 févr, vol.50, issue.21, 2010. ,
Pneumocystis jirovecii colonization in patients with systemic autoimmune diseases: prevalence, risk factors of colonization and outcome Epidemiology and clinical significance of pneumocystis colonization, Rheumatol Oxf Engl. mars J Infect Dis. 1 janv, vol.50197, issue.231, pp.10-17, 2008. ,
Pneumocystis jirovecii airborne transmission between critically ill patients and health care workers Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children):35?41. 26 Multi-locus genotype switching in Pneumocystis carinii sp. f. hominis: evidence for reinfection Systematic review of outbreaks of Pneumocystis jirovecii pneumonia: evidence that P. jirovecii is a transmissible organism and the implications for healthcare infection control Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients, 1716?8. 25. Pifer LL1?8. 28. Gianella S, pp.1-10, 1978. ,
colonization: frequency and putative risk factors: Table 1., Medical Mycology, vol.30, 2016. ,
DOI : 10.1093/mmy/myw113
Update on the diagnosis and treatment of Pneumocystis pneumonia Differences in the clinical characteristics of Pneumocystis jirovecii pneumonia in immunocompromized patients with and without HIV infection, 107?38. 31, pp.126-157, 2010. ,
Pneumonia: High-Resolution CT Findings in Patients With and Without HIV Infection, American Journal of Roentgenology, vol.198, issue.6, pp.555-561, 2012. ,
DOI : 10.2214/AJR.11.7329
Relationship between Radiological Stages and Prognoses of Pneumocystis Pneumonia in Non-AIDS Immunocompromised Patients, Chinese Medical Journal, vol.129, issue.17, pp.2020-2025, 2016. ,
DOI : 10.4103/0366-6999.189068
A rare cause of cavitary lung lesions CT findings in immunocompromised patients with pulmonary infections, 28?31. 36. Demirkazik FB, Akin A, pp.75-82, 2008. ,
Small-Intestine Pneumocystis jiroveci Pseudotumor as an Acquired Immunodeficiency Syndrome???Presenting Illness: Report of a Case and Review of the Literature, Archives of Pathology & Laboratory Medicine, vol.136, issue.9, pp.1001-1004, 2012. ,
DOI : 10.5858/arpa.2011-0221-CR
Pneumocystis jiroveci thyroiditis: report of 15 cases in the literature, 443?6. 39. Roux, 2007. ,
DOI : 10.1159/000333757
Human herpes virus co-infection is associated with mortality in HIV-negative patients with Pneumocystis jirovecii pneumonia, European Journal of Clinical Microbiology & Infectious Diseases, vol.362, issue.9395, pp.189-94, 2013. ,
DOI : 10.1016/S0140-6736(03)14740-X
URL : https://hal.archives-ouvertes.fr/inserm-00872789
An analysis of 78 cases Pneumocystis carinii pneumonia in critically ill patients with malignancy: a descriptive study Clin Infect Dis Off Publ Infect Dis Soc Am. 15 oct Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features Pneumocystis pneumonia in HIV-infected and immunocompromised non-HIV infected patients: a retrospective study of two centers in China, Pneumocystis carinii pneumonia in patients without AIDS Limper AH, pp.2436-2477, 1980. ,
Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed? Ups, J Med Microbiol. juill J Med Sci. mars, vol.53122, issue.1, pp.56-60, 2004. ,
Atypical Pneumocystis jiroveci pneumonia with multiple nodular granulomas after rituximab for refractory nephrotic syndrome, Pediatric Nephrology, vol.118, issue.11, pp.145-154, 2013. ,
DOI : 10.1378/chest.118.3.704
Polymerase Chain Reaction for Diagnosing Pneumocystis Pneumonia in Non-HIV Immunocompromised Patients With Pulmonary Infiltrates, 655?61. 52. Alanio A, Hauser PM, 2009. ,
DOI : 10.1378/chest.08-1309
URL : https://hal.archives-ouvertes.fr/inserm-00448960
ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients Detection of Pneumocystis jiroveci in respiratory specimens by four staining methods, J Antimicrob Chemother. sept J Clin Microbiol. juill, vol.7142, issue.97, pp.2386-96, 2004. ,
Accuracy of ?-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a metaanalysis, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. janv, vol.19, issue.11, 2013. ,
Detection of Pneumocystis carinii with DNA amplification PCR detection of Pneumocystis carinii in bronchoalveolar lavage specimens: analysis of sensitivity and specificity Evaluation of diagnostic value and epidemiological implications of PCR for Pneumocystis carinii in different immunosuppressed and immunocompetent patient groups V, Dei-Cas E. Pulmonary colonization with Pneumocystis carinii in human immunodeficiency virus-negative patients: assessing risk with blood CD4+ T cell counts al. Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia, 451?3. 571461?7. 59):1331?2. 60. Larsen HH, pp.678-81, 1990. ,
Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors Idiopathic CD4+ T-lymphocytopenia--four patients with opportunistic infections and no evidence of HIV infection Pneumocystis jiroveci pneumonia as an atypical presentation of X-linked agammaglobulinemia The Xlinked hyper-IgM syndrome: clinical and immunologic features of 79 patients, Detection of Pneumocystis jirovecii by Quantitative PCR To Differentiate Colonization and Pneumonia in Immunocompromised HIV-Positive and HIV-Negative Patients):287?94. 63373?84. 66. Picard C, Casanova J-L, Puel A. Infectious diseases in patients with IRAK-4, MyD88, NEMO, or I?B? deficiency, pp.716-723, 1993. ,
A Novel Gain-of-Function IKBA Mutation Underlies Ectodermal Dysplasia with Immunodeficiency and Polyendocrinopathy, Journal of Clinical Immunology, vol.122, issue.Suppl 2, pp.1088-99, 2013. ,
DOI : 10.1016/j.jaci.2008.08.026
Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection):478?82. 69. Picard C, Fischer A. Hematopoietic stem cell transplantation and other management strategies for MHC class II deficiency, J Microbiol Immunol Infect Wei Mian Yu Gan Ran Za Zhi. déc Immunol Allergy Clin North Am. mai, vol.4130, issue.62, pp.173-181, 2008. ,
Clinical course of patients with WASP gene mutations The role of alveolar macrophages in Pneumocystis carinii elimination from the lower respiratory tract, 456?64. 71. Limper AH, Standing, pp.12-72, 1996. ,
Cell population obtained by bronchoalveolar lavage in Pneumocystis carinii pneumonitis, Acta Cytol. oct, vol.29, issue.5, pp.721-727, 1985. ,
Decreased apoptophagocytic gene expression in the macrophages of systemic lupus erythematosus patients, 133?45. 74. Ezekowitz RA, 2014. ,
Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 beta-glucan receptor Pneumocystis carinii cell wall beta-glucans initiate macrophage inflammatory responses through NF-kappaB activation Pneumocystis-mediated IL-8 release by macrophages requires coexpression of mannose receptors and TLR2 Scavenger receptor A dampens induction of inflammation in response to the fungal pathogen Pneumocystis carinii, ):1677?88. 76. Lebron F,205?11. 78. Hollifield M):3999?4005. 79. Walsh TJ, Gamaletsou MN. Treatment of fungal disease in the setting of neutropenia, 2003. ,
Cellular profiles in bronchoalveolar lavage fluid of HIV-infected patients with pulmonary symptoms, AIDS, vol.5, issue.5, 1991. ,
DOI : 10.1097/00002030-199105000-00008
Pneumocystis cell wall beta-glucans induce dendritic cell costimulatory molecule expression and inflammatory activation through a Fas-Fas ligand mechanism Delayed inflammatory response to Pneumocystis carinii infection in neonatal mice is due to an inadequate lung environment, J Immunol Baltim Md J Immunol Baltim Md, vol.177165, issue.8411, pp.6480-6486, 1950. ,
The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection T cell costimulatory molecule function determines susceptibility to infection with Pneumocystis carinii in mice The host response of CD28-deficient mice to Pneumocystis infection, 3055?61. 881969?77. 89. Rose CM,23?8. 90. Zwar TD, van Driel IR, Gleeson PA. Guarding the immune system: suppression of autoimmunity by CD4+CD25+ immunoregulatory T cells, pp.161-5487, 1950. ,
CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice, European Journal of Immunology, vol.32, issue.5, pp.1282-91, 2002. ,
DOI : 10.1002/1521-4141(200205)32:5<1282::AID-IMMU1282>3.0.CO;2-#
Regulatory T cells dampen pulmonary inflammation and lung injury in an animal model of pneumocystis pneumonia Immunemediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia, J Immunol Baltim Md J Clin Invest. nov, vol.177104, issue.99, pp.1307-1324, 1950. ,
Sensitized CD8+ T cells fail to control organism burden but accelerate the onset of lung injury during Pneumocystis carinii pneumonia TNF receptor signaling contributes to chemokine secretion, inflammation, and respiratory deficits during Pneumocystis pneumonia IFN-gamma and CD8+ T cells restore host defenses against Pneumocystis carinii in mice depleted of CD4+ T cells In vitro effector activity of Pneumocystis murina-specific T-cytotoxic-1 CD8+ T cells: role of granulocyte-macrophage colony-stimulating factor, 6310?6. 952511?21. 96. Kolls JK, pp.7450-7457, 1950. ,
immunology, Future Microbiology, vol.77, issue.1, pp.43-65, 2010. ,
DOI : 10.1128/IAI.01208-08
Lymphocytes Are Required during the Early Priming of CD4+ T Cells for Clearance of Pneumocystis Infection in Mice, J Immunol Baltim Md, vol.195, issue.2, pp.611-631, 1950. ,
B Cells Are Required for Generation of Protective Effector and Memory CD4 Cells in Response to Pneumocystis Lung Infection, The Journal of Immunology, vol.176, issue.10, pp.6147-54, 1950. ,
DOI : 10.4049/jimmunol.176.10.6147
Anti-CD20 Antibody Therapy and Susceptibility to Pneumocystis Pneumonia, Infection and Immunity, vol.83, issue.5, pp.2043-52, 2015. ,
DOI : 10.1128/IAI.03099-14
Humoral immunity in experimental Pneumocystis carinii infection. I. Serum and bronchial lavage fluid antibody responses in rats, J Lab Clin Med. juin, vol.97, issue.6, pp.820-853, 1981. ,
Complement and Fc Function Are Required for Optimal Antibody Prophylaxis against Pneumocystis carinii Pneumonia, Infection and Immunity, vol.74, issue.1, pp.390-393, 2006. ,
DOI : 10.1128/IAI.74.1.390-393.2006
Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models., Journal of Clinical Investigation, vol.81, issue.6 ,
DOI : 10.1172/JCI113503
Passive Intranasal Monoclonal Antibody Prophylaxis against Murine Pneumocystis carinii Pneumonia, Infection and Immunity, vol.70, issue.3, pp.1069-74, 2002. ,
DOI : 10.1128/IAI.70.3.1069-1074.2002
Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient scid mice, Infect Immun. mai, vol.61, issue.5, pp.1641-1650, 1993. ,
Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice, Infect Immun. juill, vol.63, issue.7, pp.2391-2396, 1995. ,
CD4+ T cell???independent vaccination against Pneumocystis carinii in mice, Journal of Clinical Investigation, vol.108, issue.10, pp.1469-74, 2001. ,
DOI : 10.1172/JCI13826
Coinfection, Journal of Infectious Diseases, vol.213, issue.10, pp.1586-95, 2016. ,
DOI : 10.1093/infdis/jiw032
A double-edged sword [Internet]. [cité 5 mars 2017]. Disponible sur ,
The new paradigm of T-cell homeostatic proliferation-induced autoimmunity, Trends in Immunology, vol.26, issue.1, pp.5-8, 2005. ,
DOI : 10.1016/j.it.2004.11.006
Leukopenia, lymphopenia, and neutropenia in systemic lupus erythematosus: Prevalence and clinical impact???A systematic literature review, Seminars in Arthritis and Rheumatism, vol.45, issue.2, pp.190-194, 2015. ,
DOI : 10.1016/j.semarthrit.2015.05.009
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus, Arthritis & Rheumatism, vol.65, issue.Suppl, pp.2677-86, 2012. ,
DOI : 10.1111/j.1523-1755.2004.00443.x
Systemic lupus erythematosus and lymphopenia: Clinical and pathophysiological features], Rev Med Interne. 14 févr, 2017. ,
Antilymphocyte Antibodies in Systemic Lupus Erythematosus: Association with Disease Activity and Lymphopenia, Journal of Immunology Research, vol.99, issue.2, p.672126, 2014. ,
DOI : 10.1177/0961203306071916
Lymphopenia in rheumatoid arthritis, J R Soc Med. août, vol.82, issue.8, pp.462-465, 1989. ,
Peripheral Blood Lymphocyte Subset Counts in Patients with Dermatomyositis, Medicine, vol.82, issue.2, pp.82-88, 2003. ,
DOI : 10.1097/00005792-200303000-00002
Abnormalities of lymphocyte subsets in polymyositis., BMJ, vol.287, issue.6386, pp.181-183, 1983. ,
DOI : 10.1136/bmj.287.6386.181
Lymphopenia in Wegener???s Granulomatosis, Nephron, vol.92, issue.2, pp.466-71, 2002. ,
DOI : 10.1159/000063303
The immune paradox of sarcoidosis and regulatory T cells, The Journal of Experimental Medicine, vol.83, issue.2, pp.359-70, 2006. ,
DOI : 10.1164/ajrccm.160.5.9904045
Lack of immune deficiency in sarcoidosis: compartmentalisation of the immune response., Thorax, vol.42, issue.4, pp.250-255, 1987. ,
DOI : 10.1136/thx.42.4.250
Does peripheral blood T-lymphocyte population distribution in sarcoidosis provide a prognostic clue? Sarcoidosis, sept, vol.8, issue.2, pp.129-162, 1991. ,
Opportunistic infections and sarcoidosis], Rev Med Interne, 2016. ,
Prognostic Significance of Severe Preoperative Lymphopenia in Patients with Crohn??s Disease, Annals of Surgery, vol.203, issue.2, pp.132-137, 1986. ,
DOI : 10.1097/00000658-198602000-00004
The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus-negative immunocompromised patients: A systematic review, Transpl Infect Dis Off J Transplant Soc. 30 déc, 2016. ,
Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases, J Rheumatol. févr, vol.21, issue.2, pp.246-51, 1994. ,
Pneumocystis carinii Pneumonia in Patients Without AIDS, Clinical Infectious Diseases, vol.17, issue.Supplement_2, pp.416-422, 1993. ,
DOI : 10.1093/clinids/17.Supplement_2.S416
Role of primary prophylaxis for pneumocystis pneumonia in patients treated with systemic corticosteroids or other immunosuppressive agents for immune-mediated dermatologic conditions, Journal of the American Academy of Dermatology, vol.63, issue.5, pp.815-838, 2010. ,
DOI : 10.1016/j.jaad.2009.11.588
Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis, European Journal of Clinical Investigation, vol.9, issue.Suppl 1, pp.346-68, 2015. ,
DOI : 10.1038/nrrheum.2013.134
Pneumocystis carinii pneumonia in patients with connective tissue diseases: The role of hospital experience in diagnosis and mortality, Arthritis & Rheumatism, vol.32, issue.4, pp.780-789, 1999. ,
DOI : 10.1002/1529-0131(199904)42:4<780::AID-ANR23>3.0.CO;2-M
Prevention of Infection Due to Pneumocystis spp. in Human Immunodeficiency Virus-Negative Immunocompromised Patients, Clinical Microbiology Reviews, vol.17, issue.4, pp.770-782, 2004. ,
DOI : 10.1128/CMR.17.4.770-782.2004
ERA- EDTA recommendations for the management of ANCA-associated vasculitis, Ann Rheum Dis ,
??v??nements infectieux au cours des vascularites n??crosantes syst??miques??: ??tude r??trospective de 82??cas, La Revue de M??decine Interne, vol.35, issue.10, pp.636-678, 2014. ,
DOI : 10.1016/j.revmed.2013.11.009
Polymyositis and dermatomyositis, The Lancet, vol.362, issue.9388, pp.971-82, 2003. ,
DOI : 10.1016/S0140-6736(03)14368-1
Infectious Complications in Polymyositis and Dermatomyositis: A Series of 279 Patients, Seminars in Arthritis and Rheumatism, vol.41, issue.1, pp.48-60, 2011. ,
DOI : 10.1016/j.semarthrit.2010.08.003
Risk factors for pneumocystis pneumonia in giant cell arteritis: a single-centre cohort study, Clin Exp Rheumatol. avr, vol.33, issue.2, pp.122-125, 2015. ,
Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations, Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, vol.9, issue.1, pp.29-40, 2015. ,
DOI : 10.4137/CCRPM.S23286
A Cluster of Pneumocystis jirovecii Infection Among Outpatients with Rheumatoid Arthritis, The Journal of Rheumatology, vol.37, issue.7, pp.1547-1555, 2010. ,
DOI : 10.3899/jrheum.091294
Cost-effectiveness of Prophylaxis Against Pneumocystis jiroveci Pneumonia in Patients with Crohn???s Disease, Digestive Diseases and Sciences, vol.44, issue.2014, pp.3743-55, 2015. ,
DOI : 10.1016/j.amjmed.2014.07.010
Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults, Med J Aust. 6 mars, vol.162, issue.5, pp.233-238, 1995. ,
Pneumocystis carinii Pneumonia in Patients Without Acquired Immunodeficiency Syndrome: Associated Illnesses and Prior Corticosteroid Therapy, Mayo Clinic Proceedings, vol.71, issue.1, pp.5-13, 1996. ,
DOI : 10.4065/71.1.5
Fulminant Pneumocystis carinii Pneumonia in 4 Patients With Dermatomyositis, Archives of Internal Medicine, vol.157, issue.13, pp.1501-1504, 1997. ,
DOI : 10.1001/archinte.1997.00440340145015
Le risque de pneumocystose est-il pr??visible au cours de la maladie de Wegener?, La Revue de M??decine Interne, vol.14, issue.10, p.1025, 1993. ,
DOI : 10.1016/S0248-8663(05)80142-0
Prophylactic Antibiotic Usage for Pneumocystis jirovecii Pneumonia in Patients With Systemic Lupus Erythematosus on Cyclophosphamide, JCR: Journal of Clinical Rheumatology, vol.14, issue.5, pp.267-72, 2008. ,
DOI : 10.1097/RHU.0b013e31817a7e30
Pneumocystis Carinii Pneumonia Associated with Low Dose Methotrexate Treatment for Rheumatoid Arthritis, Scandinavian Journal of Rheumatology, vol.18, issue.1, pp.51-54, 1994. ,
DOI : 10.1093/rheumatology/31.1.71
Pneumocystis carinii pneumonia in rheumatoid arthritis patients treated with methotrexate. A report of two cases, Rev Rhum Engl Ed. juin, vol.63, issue.6, pp.453-459, 1996. ,
Low-dose methotrexate as a risk factor for Pneumocystis carinii pneumonia, Mil Med. janv, vol.161, issue.1, pp.58-60, 1996. ,
Pneumocystosis in a patient with Crohn's disease treated with combination therapy with adalimumab, J Crohns Colitis. mai, vol.6, issue.4, pp.483-490, 2012. ,
Pneumocystis jiroveci pneumonia and pneumomediastinum in an anti-TNF?? naive patient with ulcerative colitis, World Journal of Gastroenterology, vol.15, issue.15, pp.1897-900, 2009. ,
DOI : 10.3748/wjg.15.1897
Pneumocystis Pneumonia During Combined Therapy of Infliximab, Corticosteroid, and Azathioprine in a Patient with Crohn???s Disease, Digestive Diseases and Sciences, vol.113, issue.6, pp.1438-1479, 2007. ,
DOI : 10.7326/0003-4819-123-2-199507150-00009
Pneumocystis jirovecii pneumonia in mycophenolate mofetil-treated patients with connective tissue disease: analysis of 17 cases, Rheumatology International, vol.41, issue.3, pp.1765-71, 2014. ,
DOI : 10.1016/j.semarthrit.2011.05.004
Fungal Infections and New Biologic Therapies, Current Rheumatology Reports, vol.64, issue.12, p.29, 2016. ,
DOI : 10.1002/acr.21784
Pneumocystis jirovecii Pneumonia in Patients Receiving Tumor-Necrosis-Factor-Inhibitor Therapy: Implications for Chemoprophylaxis, Current Rheumatology Reports, vol.64, issue.10, p.445, 2014. ,
DOI : 10.1002/acr.21805
Pneumocystis jiroveci (carinii) Pneumonia After Infliximab Therapy: A Review of 84 Cases, Digestive Diseases and Sciences, vol.126, issue.6, pp.1481-1485, 2007. ,
DOI : 10.1007/s10620-006-9250-x
Low incidence of pneumocystis pneumonia utilizing PCR-based diagnosis in patients with B-cell lymphoma receiving rituximab-containing combination chemotherapy, American Journal of Hematology, vol.35, issue.11, pp.1113-1120, 2016. ,
DOI : 10.1128/AAC.35.9.1884
Infectious events during the course of autoimmune diseases treated with rituximab: A retrospective study of 93 cases], Rev Med Interne. mars, vol.38, issue.3, pp.160-166, 2017. ,
Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies, Autoimmunity Reviews, vol.14, issue.4, pp.304-317, 2015. ,
DOI : 10.1016/j.autrev.2014.11.014
A Survey of Rheumatologists' Practice for Prescribing Pneumocystis Prophylaxis, The Journal of Rheumatology, vol.37, issue.4, pp.792-801, 2010. ,
DOI : 10.3899/jrheum.090843
Prophylaxis of Pneumocystis Pneumonia in Immunocompromised Non-HIV-Infected Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials, Mayo Clinic Proceedings, vol.82, issue.9, pp.1052-1061, 2007. ,
DOI : 10.4065/82.9.1052
An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients, American Journal of Respiratory and Critical Care Medicine, vol.183, issue.1, pp.96-128, 2011. ,
DOI : 10.1164/rccm.2008-740ST
pneumonia in patients with haematological and solid malignancies, 2014, Internal Medicine Journal, vol.57, issue.3, pp.1350-63, 2014. ,
DOI : 10.1093/cid/cit413
Pneumocystis jirovecii pneumonia in systemic autoimmune rheumatic disease: A case???control study, Seminars in Arthritis and Rheumatism, vol.46, issue.6, 2016. ,
DOI : 10.1016/j.semarthrit.2016.09.009
Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia, Pharmacotherapy. déc, vol.16, issue.6, pp.1030-1038, 1996. ,
Comparison of trimethoprim???sulfamethoxazole and aerosolized pentamidine for primary prophylaxis of Pneumocystis jiroveci pneumonia in immunocompromised patients with connective tissue disease, Rheumatology International, vol.3, issue.7, pp.673-679, 2008. ,
DOI : 10.11150/kansenshogakuzasshi1970.73.1123
Trimethoprim???Sulfamethoxazole (Co-Trimoxazole) for the Prevention of Relapses of Wegener's Granulomatosis, New England Journal of Medicine, vol.335, issue.1, pp.16-20, 1996. ,
DOI : 10.1056/NEJM199607043350103
Frequency of adverse drug reactions in patients with systemic lupus erythematosus, J Rheumatol. mars, vol.30, issue.3, pp.480-484, 2003. ,
pneumonia, in patients with connective tissue diseases, Modern Rheumatology, vol.327, issue.1, pp.62-70, 2013. ,
DOI : 10.1007/s00296-007-0505-4
A dose-escalation regimen of trimethoprim???sulfamethoxazole is tolerable for prophylaxis against Pneumocystis jiroveci pneumonia in rheumatic diseases, Modern Rheumatology, vol.15, issue.4, pp.752-760, 2013. ,
DOI : 10.1177/0961203307086640
A Meta-analysis of the Relative Efficacy and Toxicity of Pneumocystis carinii Prophylactic Regimens, Archives of Internal Medicine, vol.156, issue.2, pp.177-88, 1996. ,
DOI : 10.1001/archinte.1996.00440020081010
Methotrexate and trimethoprim-sulphamethoxazole-a potentially hazardous combination, Clinical and Experimental Dermatology, vol.26, issue.5, pp.358-60, 1990. ,
DOI : 10.1001/archinte.145.11.2035
Allergic pancytopenia to trimethoprim-sulphamethoxazole for Pneumocystis carinii pneumonia following methotrexate treatment for rheumatoid arthritis., Rheumatology, vol.38, issue.5, pp.475-481, 1999. ,
DOI : 10.1093/rheumatology/38.5.475
Pneumocystis Pneumonia, New England Journal of Medicine, vol.350, issue.24, pp.2487-98, 2004. ,
DOI : 10.1056/NEJMra032588
pneumonia infection risk factors in patients with connective tissue disease, Modern Rheumatology, vol.345, issue.5, pp.282-290, 2006. ,
DOI : 10.1165/ajrcmb.16.2.9032117
Pneumocystis pneumonia among patients with systemic diseases]. Presse Medicale Paris Fr 1983, févr, vol.38, issue.2, pp.251-260, 2009. ,